1. Europe accounts for 19.3% share of global clinical trial activity in 2020. Clinical Trials Arena. (2021, February 26).
https://www.clinicaltrialsarena.com/clinical-trials-analysis/europe-accounts-for-19-3-share-of-global-clinical-trial-activity-in-2020/
2. Deu, F. L., & Silva, J. S. da. (2019, August 23). Biotech in Europe: A strong foundation for growth and innovation. McKinsey & Company.
https://www.mckinsey.com/industries/life-sciences/our-insights/biotech-in-europe-a-strong-foundation-for-growth-and-innovation
3. Loche, A., Paolucci, N., Peters, N., & Veken, L. V. der. (2021, January 19). A call to action: Opportunities and challenges for CGTs in Europe. McKinsey & Company.
https://www.mckinsey.com/industries/life-sciences/our-insights/a-call-to-action-opportunities-and-challenges-for-cgts-in-europe
4. Voluntary Harmonisation Procedure (VHP) for the assessment of Multinational Clinical Trial Applications. Danish Medicines Agency. (2013, July 9).
https://laegemiddelstyrelsen.dk/en/news/reassessment-of-reimbursement-of-medicines-news-archives/voluntary-harmonisation-procedure-vhp-for-the-assessment-of-multinational-clinical-trial-applications/